Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

Bio-Rad Laboratories logo
$247.05 -10.70 (-4.15%)
As of 09:15 AM Eastern

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Key Stats

Today's Range
$247.05
$247.05
50-Day Range
$223.15
$264.52
52-Week Range
$225.29
$359.22
Volume
200 shs
Average Volume
207 shs
Market Capitalization
$6.72 billion
P/E Ratio
21.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BIO.B Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Bio-Rad Labs B (BIOb) Earnings Dates & Reports
Bio-Rad price target lowered to $409 from $430 at RBC Capital
See More Headlines

BIO.B Stock Analysis - Frequently Asked Questions

Bio-Rad Laboratories' stock was trading at $325.60 at the beginning of the year. Since then, BIO.B stock has decreased by 24.1% and is now trading at $247.05.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) announced its quarterly earnings data on Thursday, July, 31st. The company reported $2.61 EPS for the quarter. Bio-Rad Laboratories had a trailing twelve-month return on equity of 4.01% and a net margin of 12.50%.

Bio-Rad Laboratories subsidiaries include these companies: Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and others.

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/31/2025
Today
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
CIK
12208
Employees
8,200
Year Founded
1952

Profitability

EPS (Trailing Twelve Months)
$11.73
Trailing P/E Ratio
21.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.84 billion
Net Margins
12.50%
Pretax Margin
17.62%
Return on Equity
4.01%
Return on Assets
2.82%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
5.12
Quick Ratio
3.67

Sales & Book Value

Annual Sales
$2.57 billion
Price / Sales
2.62
Cash Flow
$10.39 per share
Price / Cash Flow
23.77
Book Value
$261.96 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
27,210,000
Free Float
19,490,000
Market Cap
$6.72 billion
Optionable
Not Optionable
Beta
0.76

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:BIO.B) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners